Rare gut condition: which surgery works best?
NCT ID NCT06970093
First seen Dec 12, 2025 · Last updated Jun 20, 2026 · Updated 28 times
Summary
This study compares two surgeries—One Anastomosis Gastric Bypass and Duodenojejunostomy—for treating Superior Mesenteric Artery Syndrome (SMAS), a rare condition where the duodenum is compressed, causing severe nausea, vomiting, and weight loss. Twenty participants were randomly assigned to one surgery and followed for 12 months to see which better improves symptoms and nutrition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WEIGHT LOSS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ain Shams University Hospitals
Cairo, Cairo Governorate, 11566, Egypt
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
One Anastomosis Gastric Bypass (OAGB) and Duodenojejunostomy (DJ) surgeries
What this could lead to
If this trial succeeds, it could show which surgery is more effective for treating SMAS, helping patients get better symptom relief and nutritional recovery.
What could go wrong
This is a small study with only 20 participants, so results may not apply to everyone. Both surgeries are invasive and carry risks like infection or complications.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.